Completed NA INTERVENTIONAL 2-arm NCT02417506

Study to Assess the Effect of E-OA-07 on Acute Pain Response in Subjects Suffering From Knee OA (Osteolanc)

A Double Blind Randomized Comparator Controlled Study to Assess the Effect of E-OA-07 (Lanconone) on Acute Pain Response in Subjects Suffering From Osteoarthritis of the Knee

Sponsor: Enovate Biolife Pvt Ltd

Conditions Osteoarthritis of Knee

Interventions E-OA-07 (Lanconone) Ibuprofen

Updated 5 times since 2017 Last updated: May 6, 2015 Started: Aug 31, 2014 Primary completion: Feb 28, 2015 Completion: Feb 28, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Osteoarthritis of Knee, this trial is completed. The trial is conducted by Enovate Biolife Pvt Ltd and has accumulated 5 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Aug 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Enovate Biolife Pvt Ltd
Vedic Lifesciences Pvt. Ltd.

Data source: Vedic Lifesciences Pvt. Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mumbai, India